Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Ortho claims agents for osteoporosis

May 24, 1996

Akzo Nobel claims contraceptive vaccines

May 17, 1996

RPR, Novo Nordisk form global HRT alliance

May 17, 1996

Yamanouchi claims antidiabetic agents

May 17, 1996

rhIL-11 reduces need for platelet transfusions in chemotherapy recipients

May 17, 1996

Positive preliminary results announced for CholestaGel phase IIa study

May 17, 1996

FO-2546F: ACAT inhibitor from Albophoma yamanashiensis

May 17, 1996

Creative Biomolecules, Stryker extend OP-1 agreement

May 17, 1996

Estraderm MX launched in U.K.

May 10, 1996

Estring approved for marketing in U.S.

May 10, 1996

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 12, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...